Curis, Inc. (CRIS)
0.4071
-0.10
(-19.86%)
USD |
NASDAQ |
Oct 16, 16:00
0.4174
+0.01
(+2.53%)
After-Hours: 20:00
Curis Net Income (Quarterly) : -8.581M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.581M |
| March 31, 2026 | -24.20M |
| December 31, 2025 | 19.36M |
| September 30, 2025 | -7.729M |
| June 30, 2025 | -8.593M |
| March 31, 2025 | -10.62M |
| December 31, 2024 | -9.618M |
| September 30, 2024 | -10.09M |
| June 30, 2024 | -11.80M |
| March 31, 2024 | -11.88M |
| December 31, 2023 | -11.71M |
| September 30, 2023 | -12.18M |
| June 30, 2023 | -11.96M |
| March 31, 2023 | -11.56M |
| December 31, 2022 | -11.33M |
| September 30, 2022 | -13.29M |
| June 30, 2022 | -15.94M |
| March 31, 2022 | -16.11M |
| December 31, 2021 | -13.62M |
| September 30, 2021 | -11.05M |
| June 30, 2021 | -10.84M |
| March 31, 2021 | -9.927M |
| December 31, 2020 | -7.517M |
| September 30, 2020 | -5.974M |
| June 30, 2020 | -6.708M |
| Date | Value |
|---|---|
| March 31, 2020 | -9.709M |
| December 31, 2019 | -8.608M |
| September 30, 2019 | -6.436M |
| June 30, 2019 | -7.213M |
| March 31, 2019 | -9.884M |
| December 31, 2018 | -5.941M |
| September 30, 2018 | -7.223M |
| June 30, 2018 | -8.664M |
| March 31, 2018 | -10.75M |
| December 31, 2017 | -8.028M |
| September 30, 2017 | -15.46M |
| June 30, 2017 | -14.09M |
| March 31, 2017 | -15.74M |
| December 31, 2016 | -11.34M |
| September 30, 2016 | -28.34M |
| June 30, 2016 | -11.29M |
| March 31, 2016 | -9.442M |
| December 31, 2015 | -13.46M |
| September 30, 2015 | -5.543M |
| June 30, 2015 | -8.129M |
| March 31, 2015 | -31.85M |
| December 31, 2014 | -5.689M |
| September 30, 2014 | -5.580M |
| June 30, 2014 | -1.896M |
| March 31, 2014 | -5.564M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 8.581M |
| EPS Diluted (Quarterly) | -4.017 |
| Enterprise Value | -3.780M |
| Earnings Yield | -3.51K% |
| Normalized Earnings Yield | -7285.88 |